Lyka Labs Ltd Performance
Day's Low
Day's High
₹140.1₹14552 Week's Low
52 Week's High
₹97.9₹172.5
| Returns % | |
| 1 Month Return | + 0.97 % |
| 3 Month Return | -7.11 % |
| 1 Year Return | + 12.27 % |
| Market Stats | |
| Previous Close | ₹143.31 |
| Open | ₹145.00 |
| Volume | 69.02K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹511.47Cr |
Lyka Labs Ltd Key Statistics
| P/E Ratio | -61.77 |
| PEG Ratio | -19.99 |
| Market Cap | ₹511.47 Cr |
| P/B Ratio | 3.88 |
| EPS | -0.79 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0 |
Lyka Labs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹511.47 Cr | 144.72% | 0.69 | -₹3 Cr | ₹111 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Lyka Labs Ltd
Share Price: ₹141.60 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹511.47Cr as of today
Revenue: ₹41.16Cr as on September 2024 (Q3 24)
Net Profit: ₹2.10Cr as on September 2024 (Q3 24)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
| Organisation | Lyka Labs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Lyka Labs Ltd
Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024
Lyka Labs reported a 53.79% increase in standalone net sales to Rs 41.16 crore for September 2024, with net profit soaring 946.01% to Rs 2.47 crore. EBITDA rose 29.01%, and EPS increased to Rs 0.69. The stock has delivered 28.05% returns over the last six months.
Lyka Labs Gains 7% on Drug Approval News - 15 Oct, 2024
Lyka Labs Ltd's shares rose 7% following CDSCO's approval for manufacturing and marketing Pregabalin Gel 8%, a significant treatment for neuropathic pain in India.
Insights on Lyka Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 40.99% to 41.08% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, LYKALABS stock has moved up by 1.0%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -2.13 Cr → 2.1 Cr (in ₹), with an average increase of 139.7% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 28.08 Cr → 41.18 Cr (in ₹), with an average increase of 17.0% per quarter
NO EFFECTFII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.15% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 46.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 113.6%
Lyka Labs Ltd Financials
Lyka Labs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 58.1% | 0.00 | |
| Foreign Institutions | 0.15% | 0.00 | |
| Mutual Funds | 0.01% | 0.00 | |
| Retail Investors | 41.08% | 0.21 | |
| Others | 0.66% |
Lyka Labs Ltd Key Indicators
Lyka Labs Ltd Valuation
Lyka Labs Ltd in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-61.77x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (23.04x)
September 5, 2022
Lyka Labs Ltd Earnings and Dividends
Lyka Labs Ltd Earnings Results
Lyka Labs Ltd’s net profit jumped 528.57% since last year same period to ₹2.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 45.83% jump in its net profits since last 3-months.
Read More about Earnings Results
Lyka Labs Ltd Technicals Summary
Bearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Lyka Labs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Lyka Labs Ltd shares.
Lyka Labs Ltd (LYKALABS) share price today is ₹141.6
Lyka Labs Ltd is listed on NSE
Lyka Labs Ltd is listed on BSE
- Today’s highest price of Lyka Labs Ltd is ₹145.
- Today’s lowest price of Lyka Labs Ltd is ₹140.1.
PE Ratio of Lyka Labs Ltd is -61.77
PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share
Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 69.02K.
Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹511.47Cr.
| Lyka Labs Ltd(LYKALABS | Price |
|---|---|
52 Week High | ₹172.5 |
52 Week Low | ₹97.9 |
Lyka Labs Ltd(LYKALABS) share price is ₹141.6. It is down -17.91% from its 52 Week High price of ₹172.5
Lyka Labs Ltd(LYKALABS) share price is ₹141.6. It is up 44.64% from its 52 Week Low price of ₹97.9
| Lyka Labs Ltd(LYKALABS | Returns |
|---|---|
1 Day Returns | -1.71% |
1 Month Returns | 0.97% |
3 Month Returns | -7.11% |
1 Year Returns | 12.27% |